Panel Roundtable

“Creative Strategic and Financing Solutions for Life Science Companies for 2024 and Beyond”

Part of the FLG Leadership Series

Tuesday, April 23rd, 2024 – 8:00 AM PST


For Life Sciences companies, from early-stage diagnostics to digital health, pre-revenue medtechs to biotechs, tight capital markets in 2024 continue to make financing a tough road for many. This is where having an experienced CFO makes all the difference. Learn from four FLG partners and experts in this sector how CEOs and boards, in partnership with their CFOs, can leverage new strategies which extend cash runways, identify creative sources of new financing for growth and make pivotal decisions about when to exit via M&A or stay the course on the road to clinical success.  

  • Discover what the latest industry metrics say about current trends in the cost of raising capital, valuations and multiples.
  • Hear from finance experts about the best ways to extend cash runways and reduce burn rates at life science companies.
  • Learn about key considerations used by CFOs as they recommend the right timing and options for capital raises.
  • Discover new strategies for creatively raising capital in today’s tight capital markets.


Meet the Panelists